Tattoos that change lives
UC Cancer Institute physicians bring 3D tattooist to campus to teach practitioners how to perform 3D areola tattoos on local patients
On Oct. 14-15, Beth Fairchild, a medical tattooist from North Carolina, visited the University of Cincinnati medical campus and taught UC Health practitioners how to perform 3D areola tattoos on patients who undergo mastectomy, reconstruction or other surgeries that leave them without natural nipples or areolae.
Elizabeth Burton was one of the patients who volunteered to be tattooed during the training, and now, she feels like her journey is complete.
Find out more about the reconstrutive team.
The UC Cancer Institute’s Breast Cancer Center will also discuss options like this and other innovations in the field at the annual educational symposium, titled “Breast Cancer Prevention, Detection and Treatment: Innovations Around Every Corner,” Saturday, Nov. 2. Learn more and register.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.